Hasil Pencarian - Umayal Sivagnanalingam

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    Residual Disease in a Novel Xenograft Model of RUNX1-Mutated, Cytogenetically Normal Acute Myeloid Leukemia.

    Residual Disease in a Novel Xenograft Model of RUNX1-Mutated, Cytogenetically Normal Acute Myeloid Leukemia. oleh Umayal Sivagnanalingam, Marlene Balys, Allison Eberhardt, Nancy Wang, Jason R Myers, John M Ashton, Michael W Becker, Laura M Calvi, Jason H Mendler

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Novel Small Molecule MEK Inhibitor URML-3881 Enhances Cisplatin Sensitivity in Clear Cell Ovarian Cancer

    Novel Small Molecule MEK Inhibitor URML-3881 Enhances Cisplatin Sensitivity in Clear Cell Ovarian Cancer oleh Rachael B. Rowswell-Turner, Jennifer A. Rutishauser, Kyu Kwang Kim, Negar Khazan, Umayal Sivagnanalingam, Aaron M. Jones, Rakesh K. Singh, Richard G. Moore

    Diterbitkan 2019-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Index case of acute myeloid leukemia in a family harboring a novel CEBPA germ line mutation

    Index case of acute myeloid leukemia in a family harboring a novel CEBPA germ line mutation oleh Jodi Ram, Gabrielle Flamm, Marlene Balys, Umayal Sivagnanalingam, Paul G. Rothberg, Anwar Iqbal, Jason R. Myers, Anthony Corbett, John M. Ashton, Jason H. Mendler

    Diterbitkan 2017-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Development of Potent Forchlorfenuron Analogs and Their Cytotoxic Effect in Cancer Cell Lines

    Development of Potent Forchlorfenuron Analogs and Their Cytotoxic Effect in Cancer Cell Lines oleh Kyu Kwang Kim, Rakesh K. Singh, Negar Khazan, Arif Kodza, Niloy A. Singh, Aaron Jones, Umayal Sivagnanalingam, Mary Towner, Hiroaki Itamochi, Rachael Turner, Richard G. Moore

    Diterbitkan 2020-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: